DFD-29 (Minocycline) Fasting + DFD-29 (Minocycline) Fed + Solodyn (Minocycline) Fasting
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pharmacokinetics
Conditions
Pharmacokinetics
Trial Timeline
May 7, 2022 → May 25, 2022
NCT ID
NCT05452785About DFD-29 (Minocycline) Fasting + DFD-29 (Minocycline) Fed + Solodyn (Minocycline) Fasting
DFD-29 (Minocycline) Fasting + DFD-29 (Minocycline) Fed + Solodyn (Minocycline) Fasting is a phase 1 stage product being developed by Dr. Reddy's Laboratories for Pharmacokinetics. The current trial status is completed. This product is registered under clinical trial identifier NCT05452785. Target conditions include Pharmacokinetics.
What happened to similar drugs?
5 of 5 similar drugs in Pharmacokinetics were approved
Approved (5) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05452785 | Phase 1 | Completed |
Competing Products
20 competing products in Pharmacokinetics